MiSeqDx

Compare MiSeqDx and MiSeq Systems
Compare MiSeqDx and MiSeq Systems

Each MiSeqDx system delivers comprehensive sequencing solutions to meet the unique needs of both healthcare providers and clinical researchers.


*Report generation is only available for the MiSeqDx Cystic Fibrosis 139-Variant Assay and the MiSeqDx Cystic Fibrosis Clinical Sequencing Assay.

540 Mb–15 Gb

output range

12-25 million

reads per run

2 × 300 bp

max read length
Interested in receiving newsletters, case studies, and information from Illumina based on your area of interest? Sign up now.
MiSeqDx Cystic Fibrosis 139-Variant Assay
MiSeqDx Cystic Fibrosis 139-Variant Assay

多様な集団における、臨床的に重要かつ機能の検証済みの嚢胞性線維症変異の大規模なパネルを備えた、FDA認可のNGSアッセイです。

MiSeqDx Cystic Fibrosis Clinical Sequencing Assay
MiSeqDx Cystic Fibrosis Clinical Sequencing Assay

FDA認可を受けた次世代シーケンスアッセイは、CFTR遺伝子のコーディング領域の全体像を提供し、嚢胞性線維症の体外診断を支援します。

MiSeqDx Universal Kit
MiSeqDx Universal Kit

分子診断ラボがMiSeqDx System用に独自の次世代シーケンスアッセイをデザインできる、検証済みのFDA認可キットです。